BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15302229)

  • 21. GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice.
    Hansotia T; Drucker DJ
    Regul Pept; 2005 Jun; 128(2):125-34. PubMed ID: 15780432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prior in vitro exposure to GLP-1 with or without GIP can influence the subsequent beta cell responsiveness.
    Delmeire D; Flamez D; Moens K; Hinke SA; Van Schravendijk C; Pipeleers D; Schuit F
    Biochem Pharmacol; 2004 Jul; 68(1):33-9. PubMed ID: 15183115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tyr1 and Ile7 of glucose-dependent insulinotropic polypeptide (GIP) confer differential ligand selectivity toward GIP and glucagon-like peptide-1 receptors.
    Moon MJ; Kim HY; Kim SG; Park J; Choi DS; Hwang JI; Seong JY
    Mol Cells; 2010 Aug; 30(2):149-54. PubMed ID: 20799012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis.
    Pamir N; Lynn FC; Buchan AM; Ehses J; Hinke SA; Pospisilik JA; Miyawaki K; Yamada Y; Seino Y; McIntosh CH; Pederson RA
    Am J Physiol Endocrinol Metab; 2003 May; 284(5):E931-9. PubMed ID: 12540373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GIP(6-30amide) contains the high affinity binding region of GIP and is a potent inhibitor of GIP1-42 action in vitro.
    Gelling RW; Coy DH; Pederson RA; Wheeler MB; Hinke S; Kwan T; McIntosh CH
    Regul Pept; 1997 Apr; 69(3):151-4. PubMed ID: 9226399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GIP(3-30)NH
    Sparre-Ulrich AH; Gabe MN; Gasbjerg LS; Christiansen CB; Svendsen B; Hartmann B; Holst JJ; Rosenkilde MM
    Biochem Pharmacol; 2017 May; 131():78-88. PubMed ID: 28237651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucose-dependent insulinotropic polypeptide stimulated insulin release from a tumor-derived beta-cell line (beta TC3).
    Kieffer TJ; Verchere CB; Fell CD; Huang Z; Brown JC; Pedersen RA
    Can J Physiol Pharmacol; 1993 Dec; 71(12):917-22. PubMed ID: 7910109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucagon-like-peptide-1 secretion from canine L-cells is increased by glucose-dependent-insulinotropic peptide but unaffected by glucose.
    Damholt AB; Buchan AM; Kofod H
    Endocrinology; 1998 Apr; 139(4):2085-91. PubMed ID: 9528997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional expression of the rat pancreatic islet glucose-dependent insulinotropic polypeptide receptor: ligand binding and intracellular signaling properties.
    Wheeler MB; Gelling RW; McIntosh CH; Georgiou J; Brown JC; Pederson RA
    Endocrinology; 1995 Oct; 136(10):4629-39. PubMed ID: 7664683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat.
    Tseng CC; Kieffer TJ; Jarboe LA; Usdin TB; Wolfe MM
    J Clin Invest; 1996 Dec; 98(11):2440-5. PubMed ID: 8958204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization and biological actions of N-terminal truncated forms of glucose-dependent insulinotropic polypeptide.
    Kerr BD; Flatt AJ; Flatt PR; Gault VA
    Biochem Biophys Res Commun; 2011 Jan; 404(3):870-6. PubMed ID: 21184739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular interactions of full-length and truncated GIP peptides with the GIP receptor - A comprehensive review.
    Gabe MBN; van der Velden WJC; Smit FX; Gasbjerg LS; Rosenkilde MM
    Peptides; 2020 Mar; 125():170224. PubMed ID: 31809770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-function analysis of a series of novel GIP analogues containing different helical length linkers.
    Manhart S; Hinke SA; McIntosh CH; Pederson RA; Demuth HU
    Biochemistry; 2003 Mar; 42(10):3081-8. PubMed ID: 12627975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.
    Vilsbøll T; Knop FK; Krarup T; Johansen A; Madsbad S; Larsen S; Hansen T; Pedersen O; Holst JJ
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4897-903. PubMed ID: 14557471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding interactions of gastric inhibitory polypeptide (GIP) with its G-protein coupled receptor through NMR and molecular modeling.
    Malde AK; Srivastava SS; Coutinho EC
    J Pept Sci; 2007 May; 13(5):287-300. PubMed ID: 17437246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of amino acid variants in the human glucose-dependent insulinotropic polypeptide (GIP) receptor: the impact on the pancreatic beta cell responses and functional expression studies in Chinese hamster fibroblast cells.
    Almind K; Ambye L; Urhammer SA; Hansen T; Echwald SM; Holst JJ; Gromada J; Thorens B; Pedersen O
    Diabetologia; 1998 Oct; 41(10):1194-8. PubMed ID: 9794107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
    Vilsbøll T; Krarup T; Madsbad S; Holst JJ
    Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new pathway for glucose-dependent insulinotropic polypeptide (GIP) receptor signaling: evidence for the involvement of phospholipase A2 in GIP-stimulated insulin secretion.
    Ehses JA; Lee SS; Pederson RA; McIntosh CH
    J Biol Chem; 2001 Jun; 276(26):23667-73. PubMed ID: 11323439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved biological activity of Gly2- and Ser2-substituted analogues of glucose-dependent insulinotrophic polypeptide.
    Gault VA; Flatt PR; Harriott P; Mooney MH; Bailey CJ; O'Harte FP
    J Endocrinol; 2003 Jan; 176(1):133-41. PubMed ID: 12525257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Degradation, cyclic adenosine monophosphate production, insulin secretion, and glycemic effects of two novel N-terminal Ala2-substituted analogs of glucose-dependent insulinotropic polypeptide with preserved biological activity in vivo.
    Gault VA; O'Harte FP; Harriott P; Flatt PR
    Metabolism; 2003 Jun; 52(6):679-87. PubMed ID: 12800091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.